All Stories

  1. Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice
  2. Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
  3. Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
  4. Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus
  5. Mucosal Immunization with Recombinant Adenovirus Encoding Soluble Globular Head of Hemagglutinin Protects Mice Against Lethal Influenza Virus Infection
  6. Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice
  7. Strategies for Control of Pandemic Influenza: Active and Passive Immunization
  8. Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza
  9. Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice
  10. Oral immunization: an update
  11. Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice
  12. Mechanism of heterosubtypic immunity to influenza A virus infection
  13. Analysis of influenza specific CTL responses in children using fibroblasts as stimulator and target cells
  14. Heterosubtypic Immunity to Influenza A Virus Infection Requires B Cells but Not CD8 + Cytotoxic T Lymphocytes
  15. Heterosubtypic Immunity to Lethal Influenza A Virus Infection Is Associated with Virus-Specific CD8+Cytotoxic T Lymphocyte Responses Induced in Mucosa-Associated Tissues